Sentence examples for subsequent manufacturing process from inspiring English sources

In addition, changes to some assay ranges were implemented for the subsequent manufacturing process: C3adesArg was changed from 0 – 1.8 μg/mL to 0 – 600 ng/mL, M-CSF from 0 – 1 ng/mL to 0 – 500 pg/mL, NNMT from 0 – 50 ng/mL to 0 – 70 ng/mL and S100A11 changed from 0 – 50 ng/mL to 0 – 200 ng/mL.

The implications of the decisions in the design phase on the subsequent manufacturing processes are considered vital.

The performance of the extruded profile in subsequent manufacturing processes such as bending or forming is limited by the strength of the weakest weld.

Refinement in the powder manufacturing process and subsequent treatments are required to meet the specification challenges for commercially produced cold spray powders.

Friction drilling, as forming process with subsequent manufacturing of threads, offers the opportunity to produce an internal thread in lightweight profiles with a usable thread depth larger than the profile thickness, making use of local material expansion.

This research examined a high shear wet granulation process and subsequent manufacturing of a tablet containing a biopharmaceutics classification system (BCS) class II drug, gliclazide (low solubility, high permeability).

This paper addresses a multi-stage and multi-period supply chain network design problem in which multiple commodities should be produced through different subsequent levels of manufacturing processes.

In the subsequent section, we will discuss the piston manufacturing process and its further division into subsystems in order to develop the stochastic models.

Hydrazine is a contaminant in MH that derives partly from the manufacturing process and partly from subsequent breakdown of MH (particularly the formulation conjugated with diethanolamine, MH-30) [30].

Subsequent improvements were almost entirely concerned with the manufacturing process and with the ability to purify and control the quality of the ingredients.

This may be based on the principle that it is common for originator biologics to undergo manufacturing process improvements over time that trigger subsequent comparability exercises [ 35].